Barclays Maintains an 'Overweight' on Entropic (ENTR); December Ahead, March Raised
Tweet Send to a Friend
Barclays maintains an 'Overweight' on Entropic (NASDAQ: ENTR), PT $14.
Barclays analyst says, "We emerge encouraged by strong results and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "We emerge encouraged by strong results and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
